Across TCGA pan-cancer cohorts, RNU7-147P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU7-147P data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNU7-147P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-147P expression acts as an unfavorable survival marker.
SKCM and STAD are the cancer types where RNU7-147P RNA most reproducibly stratifies survival.